Hello,   I work at athenahealth (EMR Vendor) and we are currently in the process of implementing eCQMs in order to support our clients during the 2019 Performance Year. We need some clarification on the measure guidance for CMS156 with regards to the MIPs program:   The measure guidance for CMS156 (Use of High-Risk Medications in the Elderly) reads: The intent of the measure is to assess if the reporting provider ordered the high-risk medication(s). If the patient had a high-risk medication previously prescribed by another provider, they would not be counted towards the numerator unless the reporting provider also ordered a high-risk medication for them. Therefore, this would indicate that only actions done by the provider reporting the patient would be considered when evaluating the satisfaction of the patient. For example,   Provider A sees patient, who falls into denominator Provider B orders medication that would satisfy the numerator for the patient Provider A reports 0/1 for the measure because the action of Provider B does not count for the patient.   Is this interpretation correct for the MIPS Quality Category? A representative from the CPC+ program seems to contradict the guidance: https://oncprojectracking.healthit.gov/support/browse/CQM-2950?jql=text%20~%20%22cms%20156%22   The thread above makes it seem like results for all providers within the same group should all be counted, instead of individuals. This distinction is not documented in the CQL, which makes this case ambiguous for us.   Thanks, Harrison